	Gastos De Venta Y Administración		Fecha
Agios Pharmaceuticals	USD 41.27M	4.6M	2025-09
ALKERMES	USD 171.77M	17.9M	2025-09
Alterity Therapeutics Limited	AUD 2.29M	649.1K	2023-06
Amgen	USD 1.94B	237M	2025-12
Baxter International	USD 708M	10M	2025-09
BioCryst Pharmaceuticals	USD 80.47M	15.39M	2024-12
Biogen	USD 545.2M	38.6M	2025-09
Bristol-Myers Squibb	USD 2.18B	392M	2025-12
Cara Therapeutics	USD 4.64M	2.19M	2025-03
Cipla	INR 13.25B	101.8M	2025-12
Dr.Reddys Laboratories	INR 26.92B	482M	2025-12
Eisai	JPY 111.72B	7.86B	2025-12
Eli Lilly	USD 3.13B	391.3M	2025-12
Esperion Therapeutics	USD 39.98M	4.21M	2024-09
Exelixis	USD 103.13M	9.8M	2025-09
Gilead Sciences	USD 1.35B	6M	2025-09
GlaxoSmithKline	GBP 2.68B	518M	2025-12
Grifols	EUR 333.1M	157M	2025-09
Halozyme Therapeutics	USD 37.53M	4.53M	2025-09
Incyte	USD 390.41M	61.33M	2025-12
Ionis Pharmaceuticals	USD 86.56M	4.04M	2025-09
Ironwood Pharmaceuticals	USD 33.33M	2.78M	2024-12
Karyopharm Therapeutics	USD 27.19M	442K	2024-12
MacroGenics	USD 9.9M	600K	2025-09
Merck	USD 2.85B	215M	2025-12
Nektar Therapeutics	USD -0.18	0.07	2024-09
Neurocrine Biosciences	USD 291.6M	5.3M	2025-09
Novartis	USD 3.31B	134M	2025-09
Pfizer	USD 4.08B	894M	2025-12
Roche Holding	CHF 7.28B	3.99B	2025-12
Sarepta Therapeutics	USD 77.11M	7.22M	2025-09
Takeda	JPY 282.78B	29.23B	2025-12
Teva Pharmaceutical Industries	USD 1.12B	147M	2025-12
Xencor	USD 87.78M	72.66M	2025-09

Nektar Therapeutics Gastos De Venta Y Administración - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.